Diversion of drugs within health care facilities, a multiple-victim crime: patterns of diversion, scope, consequences, detection, and prevention
- PMID: 22766087
- PMCID: PMC3538481
- DOI: 10.1016/j.mayocp.2012.03.013
Diversion of drugs within health care facilities, a multiple-victim crime: patterns of diversion, scope, consequences, detection, and prevention
Abstract
Mayo Clinic has been involved in an ongoing effort to prevent the diversion of controlled substances from the workplace and to rapidly identify and respond when such diversion is detected. These efforts have found that diversion of controlled substances is not uncommon and can result in substantial risk not only to the individual who is diverting the drugs but also to patients, co-workers, and employers. We believe that all health care facilities should have systems in place to deter controlled substance diversion and to promptly identify diversion and intervene when it is occurring. Such systems are multifaceted and require close cooperation between multiple stakeholders including, but not limited to, departments of pharmacy, safety and security, anesthesiology, nursing, legal counsel, and human resources. Ideally, there should be a broad-based appreciation of the dangers that diversion creates not only for patients but also for all employees of health care facilities, because diversion can occur at any point along a long supply chain. All health care workers must be vigilant for signs of possible diversion and must be aware of how to engage a preexisting group with expertise in investigating possible diversions. In addition, clear policies and procedures should be in place for dealing with such investigations and for managing the many possible outcomes of a confirmed diversion. This article provides an overview of the multiple types of risk that result from drug diversion from health care facilities. Further, we describe a system developed at Mayo Clinic for evaluating episodes of potential drug diversion and for taking action once diversion is confirmed.
Copyright © 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
A need to establish programs to detect and prevent drug diversion.Mayo Clin Proc. 2012 Jul;87(7):607-9. doi: 10.1016/j.mayocp.2012.05.004. Mayo Clin Proc. 2012. PMID: 22766079 Free PMC article. No abstract available.
Similar articles
-
A need to establish programs to detect and prevent drug diversion.Mayo Clin Proc. 2012 Jul;87(7):607-9. doi: 10.1016/j.mayocp.2012.05.004. Mayo Clin Proc. 2012. PMID: 22766079 Free PMC article. No abstract available.
-
Guidelines for the prevention and detection of controlled substance diversion.Hosp Pharm. 1988 Dec;23(12):1057-9. Hosp Pharm. 1988. PMID: 10291230
-
Media coverage of controlled substance diversion through theft or loss.J Am Pharm Assoc (2003). 2004 Jul-Aug;44(4):439-44. doi: 10.1331/1544345041475779. J Am Pharm Assoc (2003). 2004. PMID: 15372864
-
Diversion of Controlled Drugs in Hospitals: A Scoping Review of Contributors and Safeguards.J Hosp Med. 2019 Jul;14(7):419-428. doi: 10.12788/jhm.3228. J Hosp Med. 2019. PMID: 31251158
-
Nurse drug diversion and nursing leader's responsibilities: legal, regulatory, ethical, humanistic, and practical considerations.JONAS Healthc Law Ethics Regul. 2011 Jan-Mar;13(1):13-6. doi: 10.1097/NHL.0b013e31820bd9e6. JONAS Healthc Law Ethics Regul. 2011. PMID: 21343743 Review.
Cited by
-
Controlled substance diversion in health systems: A failure modes and effects analysis for prevention.Am J Health Syst Pharm. 2019 Jul 18;76(15):1158-1164. doi: 10.1093/ajhp/zxz116. Am J Health Syst Pharm. 2019. PMID: 31408513 Free PMC article.
-
Diversion Inattention: Time for Action!Can J Hosp Pharm. 2019 May-Jun;72(3):171-172. Epub 2018 Jun 30. Can J Hosp Pharm. 2019. PMID: 31258160 Free PMC article. No abstract available.
-
Population prevalence of antiretroviral therapy sharing and its association with HIV viremia in rural Uganda: a cross-sectional population-based study.J Int AIDS Soc. 2023 Sep;26(9):e26135. doi: 10.1002/jia2.26135. J Int AIDS Soc. 2023. PMID: 37705364 Free PMC article.
-
Impact of an enterprise controlled substance management system on labor and inventory costs.Am J Health Syst Pharm. 2025 Apr 17;82(8):427-434. doi: 10.1093/ajhp/zxae305. Am J Health Syst Pharm. 2025. PMID: 39460665 Free PMC article.
-
Comparison of 3 Surveillance Methods to Detect Potential Controlled Substance Diversion in an Academic Medical Center.Hosp Pharm. 2020 Oct;55(5):323-331. doi: 10.1177/0018578719844170. Epub 2019 Apr 29. Hosp Pharm. 2020. PMID: 32999502 Free PMC article.
References
-
- Drug Abuse Prevention and Control 21 USC Chapter 13 (2011) http://uscode.house.gov/download/pls/21C13.txt Accessed March 19, 2012.
-
- National Association of Drug Diversion Investigators (NADDI) Web site http://naddi.associationdatabase.com/aws/NADDI/pt/sp/Home_Page Accessed March 19, 2012.
-
- U.S. Prescription Drug Sales Grow Slowly; Hydrocodone Most Prescribed Seeking Alpha Web site. http://seekingalpha.com/article/128003-u-s-prescription-drug-sales-grow-... Accessed March 19, 2012.
-
- National Institute on Drug Abuse (NIDA) Prescription medications: brief description. http://www.nida.nih.gov/drugpages/prescription.html Accessed March 19, 2012.
-
- Alexander B.H., Checkoway H., Nagahama B.A., Domino K.B. Cause-specific mortality risks of anesthesiologists. Anesthesiology. 2000;93(4):922–930. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical